Literature DB >> 11054133

Frequency of His1069Gln and Gly1267Lys mutations in Polish Wilson's disease population.

B Tarnacka1, G Gromadzka, M Rodo, P Mierzejewski, A Czloonkowska.   

Abstract

Wilson's disease is an autosomal recessive disorder. More than 60 mutations of the Wilson's disease gene have been described so far. We have analysed 148 Polish Wilson's disease patients from 95 families for His1069Gln and Gly1267Lys mutations and correlated this finding with age and clinical form of the disease at presentation. To identify these mutations, single strand conformation polymorphism analysis was performed. In our group there were 94 patients with neurological presentation, 28 with hepatic presentation, whilst 26 were in a pre-clinical stage of the disease. His1069Gln mutation was present on 171 (57%) of the 296 studied chromosomes, and Gly1267Lys mutation was present on 27 chromosomes (9.1%). Most of our patients were homozygous or heterozygous for His1069Gln mutation (39.9% and 30.4%, respectively); 4% of the patients were homozygous for Gly1267Lys mutation and 5.4% had both of these described mutations on their chromosomes. His1069Gln and Gly1267Lys mutations occurred often in our Wilson's disease patient population but we did not find any relationship between investigated mutations and the clinical form of Wilson's disease or age of first symptoms.

Entities:  

Mesh:

Year:  2000        PMID: 11054133     DOI: 10.1046/j.1468-1331.2000.t01-1-00112.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  9 in total

Review 1.  Genetics and epigenetic factors of Wilson disease.

Authors:  Valentina Medici; Janine M LaSalle
Journal:  Ann Transl Med       Date:  2019-04

2.  Homozygosity for Non-H1069Q Missense Mutations in ATP7B Gene and Early Severe Liver Disease: Report of Two Families and a Meta-analysis.

Authors:  Julnar Usta; Hussein Abu Daya; Houssam Halawi; Ibraheem Al-Shareef; Omar El-Rifai; Ahmad H Malli; Ala I Sharara; Robert H Habib; Kassem Barada
Journal:  JIMD Rep       Date:  2011-11-08

3.  Analysis of most common mutations R778G, R778L, R778W, I1102T and H1069Q in Indian Wilson disease patients: correlation between genotype/phenotype/copper ATPase activity.

Authors:  Sandeep Kumar; Baburam Thapa; Gurjit Kaur; Rajendra Prasad
Journal:  Mol Cell Biochem       Date:  2006-12-08       Impact factor: 3.396

Review 4.  Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes.

Authors:  P de Bie; P Muller; C Wijmenga; L W J Klomp
Journal:  J Med Genet       Date:  2007-08-23       Impact factor: 6.318

5.  High frequency of the c.3207C>A (p.H1069Q) mutation in ATP7B gene of Lithuanian patients with hepatic presentation of Wilson's disease.

Authors:  Laimutis Kucinskas; Jolanta Jeroch; Astra Vitkauskiene; Raimundas Sakalauskas; Vitalija Petrenkiene; Vaidutis Kucinskas; Rima Naginiene; Hartmut Schmidt; Limas Kupcinskas
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

6.  Correlation of ATP7B genotype with phenotype in Chinese patients with Wilson disease.

Authors:  Xiao-Qing Liu; Ya-Fen Zhang; Tze-Tze Liu; Kwang-Jen Hsiao; Jian-Ming Zhang; Xue-Fan Gu; Ke-Rong Bao; Li-Hua Yu; Mei-Xian Wang
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

Review 7.  Wilson's disease and other neurological copper disorders.

Authors:  Oliver Bandmann; Karl Heinz Weiss; Stephen G Kaler
Journal:  Lancet Neurol       Date:  2015-01       Impact factor: 44.182

8.  Mutation analysis of the ATP7B gene and genotype-phenotype correlation in Chinese patients with Wilson disease.

Authors:  Mingming Li; Jing Ma; Wenlong Wang; Xu Yang; Kaizhong Luo
Journal:  BMC Gastroenterol       Date:  2021-09-01       Impact factor: 3.067

9.  Clinical Use of Next-Generation Sequencing in the Diagnosis of Wilson's Disease.

Authors:  Dániel Németh; Kristóf Árvai; Péter Horváth; János Pál Kósa; Bálint Tobiás; Bernadett Balla; Anikó Folhoffer; Anna Krolopp; Péter András Lakatos; Ferenc Szalay
Journal:  Gastroenterol Res Pract       Date:  2015-12-24       Impact factor: 2.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.